Use of gabapentinoid treatment and the risk of self-harm: population based self-controlled case series study
A. Yuen(University College London Hospitals NHS Foundation Trust), Kenneth K. C. Man(University College London Hospitals NHS Foundation Trust), Frank Besag(Epilepsy Research UK), Adrienne Y L Chan(Aston University), Wallis C. Y. Lau(University College London Hospitals NHS Foundation Trust), Ian Chi Kei Wong(Blacktown & Mount Druitt Hospital), Boqing Chen(University College London Hospitals NHS Foundation Trust), Li Wei(University College London), Joseph Hayes(University of London), David Osborn(University College London)
Cited by 6
Related Papers
Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post‐Fracture Treatment, and All‐Cause Mortality
|Journal of Bone and Mineral Research|2023|506
Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000–2014
|The British Journal of Psychiatry|2017|474
Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
|The Lancet Infectious Diseases|2021|251
Short- and potential long-term adverse health outcomes of COVID-19: a rapid review
|Emerging Microbes & Infections|2020|240
Nonconvulsive status epilepticus: Epilepsy Research Foundation Workshop Reports
|Epileptic Disorders|2005|181